No Detail Found!

Effect of acetaminophen on progression of renal damage in adenine- induced renal failure model rat

Author(s)
Daisuke Kadowaki Graduate School of Pharmaceutical Sciences and Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
Satomi Sumikawa Graduate School of Pharmaceutical Sciences,Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan
Yuki Narita Graduate School of Pharmaceutical Sciences and Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
Kazuaki Taguchi Graduate School of Pharmaceutical Sciences,Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan
Yoichi Ishitsuka Graduate School of Pharmaceutical Sciences and Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
Tetsumi Irie Graduate School of Pharmaceutical Sciences and Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
Toru Maruyama Graduate School of Pharmaceutical Sciences and Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
Masaki Otagiri Faculty of Pharmaceutical Sciences, Sojo University,4-22-1 Ikeda, Kumamoto 860-0082,Japan
Sumio Hirata Graduate School of Pharmaceutical Sciences and Center for Clinical Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan
Abstract
Acetaminophen is known as a safety antipyretic and analgesic drug within clinicallyrecommended dosage, whereas acetaminophen overdose causes fatal and nonfatal liver or renal damage. Most of the nonsteroidal anti-inflammatory drug acts to control of pain reduces prostaglandin by inhibition of cyclooxygenase and exerts reduction of renal blood flow as well as analgesic effects. Therefore, nonsteroidal anti-inflammatory drug such as indomethacin is of particular concern for chronic kidney disease patients. To evaluate whether acetaminophen effects progression of renal failure, we examined the effects of oral administration of acetaminophen (150 mg/kg or 750 mg/kg) or indomethacin (5 mg/kg) for 4 weeks on renal function and oxidative stress in adenineinduced chronic renal failure model rats. Plasma concentrations of acetaminophen and metabolites were also measured during the treatment periods. The indomethacin administration was significantly decreased survival of the model rats. Whereas, both low dose (150 mg/kg) and high dose (750 mg/kg) acetaminophen groups indicated improved survival rate compared with indomethacin group. Progression of renal failure attenuated with acetaminophen 750 mg/kg after administration for 2 weeks, and maintained for 4 weeks. While, acetaminophen administration did not affect with liver function. Furthermore, acetaminophen metabolites were accumulated in plasma. Glutathione concentration in plasma was significantly recovered by acetaminophen administration. In conclusion, acetaminophen has no effect on the progression of renal damage, in part via its antioxidant effects, in adenine-induced renal failure model rat, indicating that acetaminophen might be good tolerability in chronic kidney disease patients.
Publication Details
Page(s) 106-106
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 3, Issue: 1, Year: 2012

Request the full text from PASTIC

0

Citations

0

Downloads

12

Views